Sign Up Today and Learn More About miDiagnostics Stock
Invest in or calculate the value of your shares in miDiagnostics or other pre-IPO companies through EquityZen's platform.
miDiagnostics Stock (MIDA)
miDiagnostics is developing a next-generation diagnostic platform based on a silicon nanofluidic processor.
About miDiagnostics Stock
Founded
2015
Industries
Travel and Tourism, Space, Manufacturing
miDiagnostics Press Mentions
Stay in the know about the latest news on miDiagnostics
Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034
globenewswire • Oct 30, 2025
System For Analysis
patents • May 04, 2025
System for nucleic acid analysis
patents • May 04, 2025
Integrated sampling and analysis device
patents • May 04, 2025
A microfluidic system
patents • May 04, 2025
miDiagnostics Management
Leadership team at miDiagnostics
Chief Technology Officer & Co-Founder
Nicolas Vergauwe
Chief Executive Officer
Katleen Verleysen
Join now and verify your accreditation status to gain access to:
- miDiagnostics Current Valuation
- miDiagnostics Stock Price
- miDiagnostics Management
- Available deals in miDiagnostics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- miDiagnostics Cap Table and Funding History by Share Class and Liquidity Preferences
- miDiagnostics Revenue and Financials
- miDiagnostics Highlights
- miDiagnostics Business Model
- miDiagnostics Risk Factors
- miDiagnostics Research Report from SACRA Research
Trading miDiagnostics Stock
How to invest in miDiagnostics stock?
Accredited investors can buy pre-IPO stock in companies like miDiagnostics through EquityZen funds. These investments are made available by existing miDiagnostics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell miDiagnostics stock?
Shareholders can sell their miDiagnostics stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
